biblio

Filters: Author is Koratkar, Santosh  [Clear All Filters]
2018
S. B. Agawane, Gupta, V. S., Kulkarni, M. J., Bhattacharya, A. K., and Koratkar, S., “Chemo-biological evaluation of antidiabetic activity of M entha arvensis L. and it's role in inhibition of advanced glycation end products”, Journal of Ayurveda and integrative medicine, 2018.
S. B. Agawane, Gupta, V. S., Kulkarni, M. J., Bhattacharya, A. K., Koratkar, S., and Rao, V. Koteswara, “Patho-physiological evaluation of Duranta erecta for the treatment of urolithiasis”, Journal of Ayurveda and integrative medicine, 2018.
2020
A. A. Shitole, Sharma, N., Giram, P., Khandwekar, A., Baruah, M., Garnaik, B., and Koratkar, S., “LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer”, Materials Science & Engineering C-Materials for Biological Applications, vol. 114, p. 111035, 2020.
2022
G. Patil, Kulsange, S., Kazi, R., Chirmade, T., Kale, V., Mote, C., Aswar, M., Koratkar, S., Agawane, S., and Kulkarni, M., “Behavioral and proteomic studies reveal methylglyoxal activate pathways associated with alzheimer’s disease”, ACS Pharmacology & Translational Science, vol. 6, no. 1, pp. 65–75, 2022.
2025
S. S. Dandekar, Thanikkal, S., Londhe, A., Bhutada, P., Saha, U., Pawar, S., Samson, R., Dharne, M., Saroj, S. D., and Koratkar, S., “Characterization of novel phages KPAФ1, KP149Ф1, and KP149Ф2 for lytic efficiency against clinical MDR Klebsiella pneumoniae infections”, Microbial Pathogenesis, vol. 202, p. 107440, 2025.